Your browser doesn't support javascript.
loading
Diabetic individuals with COVID-19 exhibit reduced efficacy of gliptins in inhibiting dipeptidyl peptidase 4 (DPP4). A suggested explanation for increased COVID-19 susceptibility in patients with type 2 diabetes mellitus (T2DM).
Mora-Rodríguez, José María; Sánchez, Belén G; Bort, Alicia; Díaz-Yuste, Alba; Ballester-González, Rubén; Arrieta, Francisco; Sebastián-Martín, Alba; Díaz-Laviada, Inés.
Afiliação
  • Mora-Rodríguez JM; Department of Systems Biology, School of Medicine and Health Sciences, Alcalá University, Alcalá de Henares, Spain; Health Research Institute of Castilla-La Mancha (IDISCAM), Spain. Electronic address: josem.mora@uah.es.
  • Sánchez BG; Department of Systems Biology, School of Medicine and Health Sciences, Alcalá University, Alcalá de Henares, Spain; Health Research Institute of Castilla-La Mancha (IDISCAM), Spain. Electronic address: belen.sanchezg@uah.es.
  • Bort A; Department of Systems Biology, School of Medicine and Health Sciences, Alcalá University, Alcalá de Henares, Spain; Health Research Institute of Castilla-La Mancha (IDISCAM), Spain. Electronic address: alicia.bort@uah.es.
  • Díaz-Yuste A; Department of Systems Biology, School of Medicine and Health Sciences, Alcalá University, Alcalá de Henares, Spain; Health Research Institute of Castilla-La Mancha (IDISCAM), Spain. Electronic address: alba.diazy@edu.uah.es.
  • Ballester-González R; Immunology Service, Ramón y Cajal Hospital, Ramón y Cajal Institute for Health Research (IRYCIS), Madrid, Spain. Electronic address: ruben.ballester@salud.madrid.org.
  • Arrieta F; Endocrinology and Nutrition Service, Ramón y Cajal University Hospital, IRYCIS, Madrid, Spain. Electronic address: farrietab.hrc@salud.madrid.org.
  • Sebastián-Martín A; Department of Systems Biology, School of Medicine and Health Sciences, Alcalá University, Alcalá de Henares, Spain; Health Research Institute of Castilla-La Mancha (IDISCAM), Spain. Electronic address: alba.sebastian@uah.es.
  • Díaz-Laviada I; Department of Systems Biology, School of Medicine and Health Sciences, Alcalá University, Alcalá de Henares, Spain; Health Research Institute of Castilla-La Mancha (IDISCAM), Spain; Chemical Research Institute "Andrés M. del Río" (IQAR), Alcalá de Henares, Spain. Electronic address: ines.diazlaviada
Life Sci ; 336: 122292, 2024 Jan 01.
Article em En | MEDLINE | ID: mdl-38030058
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Inibidores da Dipeptidil Peptidase IV / COVID-19 Limite: Humans Idioma: En Revista: Life Sci Ano de publicação: 2024 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Inibidores da Dipeptidil Peptidase IV / COVID-19 Limite: Humans Idioma: En Revista: Life Sci Ano de publicação: 2024 Tipo de documento: Article